EFFICACY OF ARIPIPRAZOLE COMBINED WITH FLUVOXAMINE IN THE TREATMENT OF CHILDHOOD OBSESSIVE-COMPULSIVE DISORDER
Jiang Guila
Abstract
Jiang Guila
Abstract
Objective To evaluate the efficacy and safety of aripiprazole combined with fluvoxamine for childhood-obsessive compulsive disorder(COCD).Methods Fifty-seven kids with COCD were randomized to fluvoxamine group(control group,n=30,fluvoxamine 200-300mg/d),and aripiprazole combined with fluvoxamine group(observation group,n=27,fluvoxamine 200-300mg/d,aripiprazole 10-20mg/d),treated for 8weeks.The efficacy and adverse reactions were assessed,before and after medication,using Yale-Brown obsessive-compulsive psychiatrists rating scale(Y-BOCS)and Hamilton anxiety scale(HAMA).The side effects were assessed using the treatment emergent symptom scale(TESS).Results Before medication,the differences of score of Y-BOCS and HAMA between the two groups were not significant(P0.05).After treatment,the Y-BOCS and HAMA scores in the observation group were lower than that in the control,the difference being significant(t=2.433,2.318;P0.05).The difference of TESS was not significant between the two groups.Conclusion Aripiprazole combined with fluvoxamine is effective and safe for patients with COCD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy and safety of aripiprazole combined with fluvoxamine for childhood-obsessive compulsive disorder(COCD).Methods Fifty-seven kids with COCD were randomized to fluvoxamine group(control group,n=30,fluvoxamine 200-300mg/d),and aripiprazole combined with fluvoxamine group(observation group,n=27,fluvoxamine 200-300mg/d,aripiprazole 10-20mg/d),treated for 8weeks.The efficacy and adverse reactions were assessed,before and after medication,using Yale-Brown obsessive-compulsive psychiatrists rating scale(Y-BOCS)and Hamilton anxiety scale(HAMA).The side effects were assessed using the treatment emergent symptom scale(TESS).Results Before medication,the differences of score of Y-BOCS and HAMA between the two groups were not significant(P0.05).After treatment,the Y-BOCS and HAMA scores in the observation group were lower than that in the control,the difference being significant(t=2.433,2.318;P0.05).The difference of TESS was not significant between the two groups.Conclusion Aripiprazole combined with fluvoxamine is effective and safe for patients with COCD.
Key concepts: Fluvoxamine, Aripiprazole, Rating scale, Psychology, Adverse effect, Internal medicine, Anxiety, Psychiatry